"The Report Candidiasis
Global Clinical Trials Review, H2, 2016 provides information on
pricing, market analysis, shares, forecast, and company profiles for
key industry participants. - MarketResearchReports.biz"
GlobalData's
clinical trial report, Candidiasis Global Clinical Trials Review, H2,
2016" provides an overview of Candidiasis clinical trials
scenario. This report provides top line data relating to the clinical
trials on Candidiasis. Report includes an overview of trial numbers
and their average enrollment in top countries conducted across the
globe. The report offers coverage of disease clinical trials by
region, country (G7 & E7), phase, trial status, end points status
and sponsor type. Report also provides prominent drugs for
in-progress trials (based on number of ongoing trials). GlobalData
Clinical Trial Reports are generated using GlobalDatas proprietary
database - Pharma eTrack Clinical trials database. Clinical trials
are collated from 80+ different clinical trial registries,
conferences, journals, news etc across the globe. Clinical trials
database undergoes periodic update by dynamic process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
View Report at:
http://www.marketresearchreports.biz/analysis/909371
Scope
- The report provides a snapshot
of the global clinical trials landscape
- Report provides top level data
related to the clinical trials by Region, Country (G7 & E7),
Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies
involved and enlists all trials (Trial title, Phase, and Status)
pertaining to the company
- The report provides all the
unaccomplished trials (Terminated, Suspended and Withdrawn) with
reason for unaccomplishment
- The Report provides enrollment
trends for the past five years
- Report provides latest news for
the past three months
Get
Sample Copy Of This Report @
Reasons to buy
- Assists in formulating key
business strategies with regards to investment
- Helps in identifying prominent
locations for conducting clinical trials which saves time and cost
- Provides top level analysis of
Global Clinical Trials Market which helps in identifying key business
opportunities
- Supports understanding of trials
count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success
rates of clinical trials by providing a comparative scenario of
completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial
assessment of the indication on a global, regional and country level
Read
our latest Press Release at
http://www.marketresearchreports.biz/pressreleases
Table of Contents
Table
of Contents
Table
of Contents 2
List
of Tables 3
List
of Figures 4
Report
Guidance 5
Clinical
Trials by Region 6
Clinical
Trials and Average Enrollment by Country 7
Top
Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top
Five Countries Contributing to Clinical Trials in Europe 10
Top
Countries Contributing to Clinical Trials in North America 11
Top
Five Countries Contributing to Clinical Trials in Middle East and
Africa 12
Top
Five Countries Contributing to Clinical Trials in Central and South
America 13
Clinical
Trials by G7 Countries: Proportion of Candidiasis to Infectious
Disease Clinical Trials 14
Clinical
Trials by Phase in G7 Countries 15
Clinical
Trials in G7 Countries by Trial Status 16
Clinical
Trials by E7 Countries: Proportion of Candidiasis to Infectious
Disease Clinical Trials 17
Clinical
Trials by Phase in E7 Countries 18
Clinical
Trials in E7 Countries by Trial Status 19
Clinical
Trials by Phase 20
In
Progress Trials by Phase 21
Clinical
Trials by Trial Status 22
Clinical
Trials by End Point Status 23
Subjects
Recruited Over a Period of Time 24
Clinical
Trials by Sponsor Type 25
Prominent
Sponsors 26
Top
Companies Participating in Candidiasis Therapeutics Clinical Trials
27
Prominent
Drugs 29
Latest
Clinical Trials News on Candidiasis 30
Nov
28, 2016: Cidara Therapeutics Presentations at ASH 2016 to Highlight
Potential Role of Novel Antifungal CD101 in Patients with Hematologic
Malignancies 30
Oct
05, 2016: SCYNEXIS Announces Complete Results from Two Phase 2
Studies of Oral SCY-078 in Patients with Candida spp. Infections and
Closing of a $15 Million Term Loan 30
Sep
12, 2016: Amplyx Pharmaceuticals Initiates Dosing in Phase 1 Clinical
Trial of APX001, a Novel Antifungal Product Candidate for Treatment
of Life-Threatening Infections 32
Clinical
Trial Profile Snapshots 33
Appendix
198
Abbreviations
198
Definitions
198
Research
Methodology 199
Secondary
Research 199
About
GlobalData 200
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment